Decisions of the Ministry of
Health of the Czech Republic have a major impact on decision-making practice in
the area of pricing and reimbursement of medicines. Knowledge of the individual
proceedings and the impact on future decisions is almost a necessity for
marketing authorisation holders. Pharmeca a.s. therefore now offers an
interactive overview of the decisions of the Ministry of Health of the Czech
Republic with more detailed information on each procedure.
As of 1 April 2023, Pharmeca a.s. offers on its website a new perspective on the decisions of the Ministry of Health of the Czech Republic in appeal proceedings in the area of pricing and reimbursement of medicines.